Comparative innate immune responses across major RNA and DNA viral infections: Mechanisms, immunopathology, and therapeutic perspectives.
Innate immune responses differ significantly between RNA and DNA viruses, influencing infection severity and therapeutic strategies.
Where it sits
this study against the rest of the cyclic glycine-proline (cgp) corpusSummary and findings
This review examines innate immune responses to major RNA and DNA viral infections, focusing on mechanisms and therapeutic perspectives. It highlights differences in interferon dynamics and immune evasion between RNA and DNA viruses. Therapeutic strategies targeting innate immunity are discussed.
Abstract
Innate immunity is the first defense against viral infections, limiting viral replication and initiating adaptive immunity. Viral pathogens are recognized by pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), (RIG-I-like receptors) RLRs, and the (cyclic GMP-AMP synthase) cGAS-STING pathway, which trigger interferon production and antiviral responses. This review compares innate immune responses to major RNA viruses (influenza, SARS-CoV-2, HIV) and DNA viruses (HSV, HBV, CMV). While these viruses activate similar pathways, they differ in interferon dynamics, inflammatory responses, immune cell activation, and immune evasion mechanisms. RNA viruses often induce rapid and strong innate responses, whereas many DNA viruses establish persistence through immune modulation. Dysregulated innate immunity can contribute to cytokine storms, chronic inflammation, and tissue damage. Therapeutic strategies targeting innate immunity, such as interferons, cytokine inhibitors, PRR agonists, and host-directed antivirals, may improve outcomes. Infection severity depends on the timing, magnitude, and regulation of innate immune responses.
Background
The study addresses how innate immune responses vary across different viral infections, which is crucial for understanding viral pathogenesis and developing therapeutic strategies. Innate immunity is the first line of defense against viruses, and its dysregulation can lead to severe outcomes. Understanding these mechanisms is important for improving treatment approaches.
Methods
This is a review article that compares innate immune responses to major RNA and DNA viruses. It discusses mechanisms such as interferon production, immune cell activation, and immune evasion. The review synthesizes existing literature without presenting new experimental data.
Results
The review highlights that RNA viruses typically induce rapid and strong innate immune responses, while DNA viruses often establish persistence through immune modulation. It discusses how dysregulated innate immunity can contribute to severe outcomes like cytokine storms. Therapeutic strategies targeting these pathways are explored.
Interpretation
The findings align with existing literature on the differences between RNA and DNA virus interactions with the innate immune system. While the review provides a comprehensive overview, the lack of new data limits its clinical applicability. The therapeutic strategies discussed are promising but require further validation in clinical trials.
Key findings
- RNA viruses like influenza and SARS-CoV-2 induce rapid and strong innate responses.
- DNA viruses such as HSV and HBV often establish persistence through immune modulation.
- Dysregulated innate immunity can lead to cytokine storms and chronic inflammation.
- Therapeutic strategies include interferons, cytokine inhibitors, and PRR agonists.
Limitations
- No new experimental data
- Relies on existing literature
- Lacks specific quantitative findings
- No direct clinical trial data discussed